HF
AXSM icon

HRT Financial’s Axsome Therapeutics AXSM Stock Holding History

HRT Financial’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.7M Buy
+178,491
New +$38.7M 0.08% 232
2026
Q1 		– Sell
-18,862
Closed -$3.26M – 3775
2025
Q4 		$3.44M Buy
18,862
+16,581
+727% +$2.31M 0.01% 971
2025
Q3 		$277K Buy
+2,281
New +$257K ﹤0.01% 2218
2025
Q2 		– Sell
-6,544
Closed -$763K – 2594
2025
Q1 		$763K Buy
+6,544
New +$746K ﹤0.01% 1257
2024
Q1 		– Sell
-9,279
Closed -$738K – 2312
2023
Q4 		$738K Sell
9,279
-3,654
-28% -$244K 0.01% 1145
2023
Q3 		$903K Buy
+12,933
New +$967K 0.01% 1040
2020
Q1 		– Sell
-40,503
Closed -$4.19M – 776
2019
Q4 		$4.19M Buy
+40,503
New +$1.64M 0.18% 91

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HRT Financial's AXSM Position: Q2 2026 in Review

HRT Financial opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 178,491 shares worth $43.7M. The stake represents 0.08% of the portfolio and ranks #232 among its holdings. This is a return to the name: HRT Financial previously reported a position in AXSM as recently as Q4 2025.

HRT Financial first reported a position in AXSM in Q4 2019 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • HRT Financial held 178,491 shares of Axsome Therapeutics worth $43.7M as of Q2 2026.
  • Axsome Therapeutics was a new HRT Financial position in Q2 2026.
  • Axsome Therapeutics made up 0.08% of HRT Financial's portfolio in Q2 2026, its #232 holding.
  • HRT Financial first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 7 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.